ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA

Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA trials appear

Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Experimental drug targets deadly heart rhythm disorder

Disease control Terminated

This early-stage study is testing whether an experimental drug called IC14 can help control arrhythmogenic cardiomyopathy, a serious heart condition that causes dangerous irregular heartbeats. Five patients who already have implanted defibrillators will receive four intravenous i…

Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA

Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA trials appear

Experimental drug targets deadly heart rhythm disorder